Chairman of the Board at Navidea Biopharmaceuticals, Inc
Dr. Rowinsky is the Executive Director, President, and Head of the Scientific Advisory Board at RGenix, a life sciences company focused on discovering new cancer targets using microRNA. He was the Head of R&D, Chief Medical Officer, and Executive Vice President of Stemline Therapeutics from 2012 to 2015. In 2010, Eric co-founded Primrose Therapeutics and became its CEO until it was acquired in 2011. From 2005 to December 2009, he served as the Chief Medical Officer and Executive Vice President of Clinical Development and Regulatory Affairs of ImClone Systems Incorporated, a life sciences company focused on monoclonal antibodies, and served on ...
Source: ImmuneXcite, Inc. on 05/24/2017
By accessing BoardEdge, you can view bios, network, connections and references of industry leading executives like Eric K. Rowinsky M.D.. More specifically, you'll be able to:
Access over 170,000 executive and board member profiles.
Example: Eric K. Rowinsky M.D.
Interested in updating your biography and work history?
We're working on making it happen.
We'll email you when this feature is available.
Please enter valid email address.
Thank you for your interest.